Incorporating AI Into Clinical Trial Operations

Clinical Scorecard: Incorporating AI Into Clinical Trial Operations

At a Glance

Category	Detail
Condition	Clinical trial operations and the use of artificial intelligence (AI) in trial workflows
Key Mechanisms	AI applications described include protocol feasibility modeling, patient prescreening, visit scheduling, consent tracking, document version control, workflow prompts, real-time data validation, signal detection, and image analysis.
Target Population	Clinical trial sponsors, contract research organizations (CROs), research sites, investigators, coordinators, and trial participants affected by operational workflows.
Care Setting	Clinical research operations across sponsor organizations, CROs, and research sites throughout the clinical trial lifecycle.

Key Highlights

The article describes AI as a potential way to improve trial efficiency and reduce administrative burden; whether efficiencies shorten development timelines depends on effective implementation and validation.
Protocol-design applications include modeling feasibility against real-world patient populations, historical enrollment patterns, and site-performance data.
Trial-execution applications include consent tracking, document version control, visit scheduling, patient recruitment, engagement and retention, and image analysis.
Real-time data validation and signal detection may help teams identify potentially actionable information earlier and improve data quality at the source.
AI may translate protocol complexity into workflow prompts, help sites remain aligned with protocol amendments, update trackers and documents, and identify potential deviations before they occur.

Guideline-Based Recommendations

Diagnosis

Management

Monitoring & Follow-up

Risks

Adding platforms and processes can create friction and slow drug development.
Administrative complexity is described as a risk factor in trial execution and is associated in the source with coordinator burnout, missed enrollment targets, and protocol deviations.
Poor-quality data can affect statistical analysis, trial timelines, costs, and interpretability.
Whether operational efficiencies shorten development timelines depends on how effectively AI is implemented and validated.

Patient & Prescribing Data

Clinical trial participants; the article discusses AI-assisted prescreening and workflow support but provides no patient-level demographic or prescribing data.

No treatment or prescribing recommendations are provided. AI is discussed as an operational support tool, including for patient prescreening, visit scheduling, and trial data workflows.